Literature DB >> 16632424

Diagnostic efficiency of sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions.

Antonio Piñero1, Pedro José Galindo, Julián Illana, Francisco Nicolás, Manuel Reus, María Dolores Hernández, Isidro Durán, Manuel Canteras, Pascual Parrilla.   

Abstract

INTRODUCTION: It would be desirable to have preoperative methods that allow an adequate selection of patients with breast lesions to rule out breast cancer. The aim of the present study is to evaluate the efficiency of preoperative Sestamibi gammagraphy and Doppler sonography regarding the differential diagnosis of malignancy in breast lesions.
MATERIAL AND METHODS: A prospective observational study was conducted on 88 consecutive patients with breast lesions. All the patients underwent preoperative Doppler sonography with an echo-enhancing agent and Sestamibi gammagraphy. All the patients had histopathological study of the surgical specimen to compare with the result of the preoperative techniques. These comparisons were done both for the overall series and separately for palpable and non-palpable lesions.
RESULTS: In the overall series results, both tests separately and the two combined, are related significantly to the malignant histological diagnosis (p < 0.001). In palpable lesions, there is a considerable increase in sensitivity, and especially in specificity, attaining 100%, with the combination of both tests. In non-palpable lesions, a relationship was only found between the results of the Sestamibi gammagraphy and the malignant histological diagnosis (93.3%; p < 0.05).
CONCLUSIONS: Sestamibi gammagraphy and Doppler sonography are two efficient exploratory techniques in the preoperative assessment of malignancy in breast lesions, especially for palpable lesions, and this efficiency is greater when they are combined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632424     DOI: 10.1007/s12094-006-0166-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  37 in total

1.  Palpable breast lesions: utility of Doppler sonography for diagnosis of malignancy.

Authors:  A Piñero; M Reus; J Illana; I Durán; E Martínez-Barba; M Canteras; P Parrilla
Journal:  Breast       Date:  2003-08       Impact factor: 4.380

2.  Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival.

Authors:  Dirk Watermann; Helmut Madjar; Willi Sauerbrei; Valerie Hirt; Heinrich Prömpeler; Elmar Stickeler
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

3.  Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.

Authors:  S Del Vecchio; A Ciarmiello; L Pace; M I Potena; M V Carriero; C Mainolfi; R Thomas; G D'Aiuto; T Tsuruo; M Salvatore
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

4.  Breast cancer cellular proliferation indexes and 99mTc-sesta Mibi capture: what correlation?

Authors:  G Bonazzi; A Cistaro; M Bellò; M Bessone; M Tetti; E Villata; C Coluccia; M Ardine; G Moz; N Massaioli; G Bisi
Journal:  J Exp Clin Cancer Res       Date:  2001-03

5.  Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.

Authors:  Hwei-Chung Wang; Shung-Shung Sun; Albert Kao; Cheng-Chieh Lin; Cheng-Chun Lee
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

Review 6.  The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer.

Authors:  A D Waxman
Journal:  Semin Nucl Med       Date:  1997-01       Impact factor: 4.446

7.  Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship?

Authors:  Antonio Piñero; Jose M Rodríguez; Enrique Martínez-Barba; Manual Canteras; Antonia Stiges-Serra; Pascual Parrilla
Journal:  Surgery       Date:  2003-07       Impact factor: 3.982

8.  Identification of angiogenesis in primary breast carcinoma according to the image analysis.

Authors:  Sung-Won Kim; Sung-Shin Park; Soo-Jung Ahn; Ki-Wook Chung; Woo Kyung Moon; Jung-Gi Im; Jeong Seok Yeo; June-Key Chung; Dong-Young Noh
Journal:  Breast Cancer Res Treat       Date:  2002-07       Impact factor: 4.872

9.  Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.

Authors:  R Taillefer; A Robidoux; R Lambert; S Turpin; J Laperrière
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

10.  Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.

Authors:  V S Lee; R H Wilkinson; G S Leight; A C Coogan; R E Coleman
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.